The three-year evolution of Germany's Digital Therapeutics reimbursement program and its path forward.

A notable trend is that most DiGA users are female, particularly in oncology, neurology, endocrinology, and gastroenterology applications.

also in 2,041 other papers

Over the three years since the program’s inception until the end of September 2023, approximately 374,000 DiGA prescriptions have been activated for patient use, reflecting an increasing trend and costing the German public health insurances approximately 113 million € 23 .

also in 33,188 other papers